SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sirna Therapeutics Inc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott Ozer who wrote (244)8/12/1999 3:25:00 PM
From: gao seng  Read Replies (1) of 562
 
Also, I am not a professional writer, so forgive me if I go astray. When a person is diagnosed with cancer, the doctor usually tells them that they can successfully kill almost all cancers. But the problem is the metastases. The article gives insight into the dilemma, and I think that radiation combined with ANGIOZYME just may well be a cure to cancer. The radiation causes the cancer to produce cancer causing compounds. The prevention of this self defense mechanism allows the positive effects of radiation to last.

I am somewhat familiar with angiogenesis compounds, and think the theories are interesting. But the identification of VEGF compounds as the method of survival by the cancer is very significant.

I also am watching ILXO for further news on this development. Dr W. from the article worked at Convergance, which has been bought out by ILXO.

However, this is the first article that says their drug stops METASTASES.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News